NOV 04, 2016 2:46 PM PDT

Scientists ID Key Protein in Ovarian Cancer's Growth

WRITTEN BY: Xuan Pham

Seeking to unravel the mysteries surrounding ovarian cancer development, researchers at the University of Michigan identified a protein that appears to be key to the cancer’s proliferation and migration.

Image credit: Pixabay.com 


The protein of interest is an epidermal growth factor protein, known as EGFL6. Proteins in this family are involved in cell growth, proliferation, and differentiation. As such, it is not hard to imagine a role for these rogue proteins in cancer development.
 
For ovarian cancer, researchers found that EGFL6 seemed to trigger cancer’s growth by 2 to 3 times the normal rate. In particular, this protein seemed to assert its effects on cancer stem cells, which can give rise to other cancer types. Of note, these types of cells are often more resistant to treatment.
 
The team found that EGFL6 spurred cancer stem cells to divide not only more often, but in an asymmetric fashion. That is, after division, the resulting daughter cells don’t have identical characteristics. This property increases the likelihood of further cancer mutations and cancer cell diversity, making it that much more difficult to treat.
 
"What this means is that the stem cell population remains stable. But the daughter cells, which can have a burst of growth, multiply and allow the cancer to grow," says Ronald J. Buckanovich, a professor of hematology/oncology and gynecologic oncology at the University of Michigan Medical School, and the study’s senior author.
 


In addition, the team found that along with abnormal growth and division, EGFL6 also made it more likely for cells to migrate. In the context of cancer, this means that the protein enables cancer cells to metastasize. Treatment of an antibody blocking EGFL6 in mice showed a significant reduction in cancer growth and metastasis – good news for treatment options in human ovarian cancer cases.
 
"The bigger implication is for women at high risk of ovarian cancer," he notes. "These patients could be treated before cancer develops, potentially blocking cancer from developing or preventing it from spreading. If cancer did develop, it could be diagnosed at an early stage, which would improve patient outcomes."
 
Ovarian cancers have one of the highest mortality rates, ranking fifth in cancer deaths among women. Of the 22,000 new estimated cases of ovarian cancer this year, only 10-15 percent of patients will be successfully treated. Thus, the team is hoping to produce a version of the EGFL6 antibody for humans, which is not yet available.

Additional source: University of Michigan Health System

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
AUG 24, 2021
Clinical & Molecular DX
A New Chapter in Metastatic Breast Cancer Biomarkers
AUG 24, 2021
A New Chapter in Metastatic Breast Cancer Biomarkers
For patients diagnosed with metastatic breast cancer, it’s often not the primary tumor that has fatal consequences ...
AUG 24, 2021
Technology
CRISPR Helps Identify New Therapeutic Target for Leukemia
AUG 24, 2021
CRISPR Helps Identify New Therapeutic Target for Leukemia
Researchers may have found a new druggable target in patients with acute myeloid leukemia (AML), thanks to a CRISPR scre ...
SEP 16, 2021
Cancer
Inspiring Hope during Childhood Cancer Awareness Month
SEP 16, 2021
Inspiring Hope during Childhood Cancer Awareness Month
Childhood cancers, also known as pediatric cancers, are diagnosed in patients up to 14 years old.  Estimates for 20 ...
OCT 25, 2021
Cell & Molecular Biology
The Labroots 2021 Cell Biology Virtual Event Poster Winner: 5-Azacytidine Treatment & Lung Cancer
OCT 25, 2021
The Labroots 2021 Cell Biology Virtual Event Poster Winner: 5-Azacytidine Treatment & Lung Cancer
Labroots virtual events are a great place to share research and learn about others work. These events feature participan ...
NOV 16, 2021
Earth & The Environment
Legal Loopholes Permitting Dangerous Air Pollution
NOV 16, 2021
Legal Loopholes Permitting Dangerous Air Pollution
A chemical plant in Port Arthur, Texas is producing ten times as much sulfur dioxide as its neighbors combined, and more ...
JAN 13, 2022
Cancer
An Arthritis Drug Combats Chemoresistance in Pancreatic Cancer
JAN 13, 2022
An Arthritis Drug Combats Chemoresistance in Pancreatic Cancer
The American Cancer Society estimates the lifetime risk of pancreatic cancer at about 1 in 64. Pancreatic duct ...
Loading Comments...